Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
AZD-5335 by AstraZeneca for Solid Tumor: Likelihood of Approval
AZD-5335 is under clinical development by AstraZeneca and currently in Phase II for Solid Tumor. According to GlobalData, Phase II...
AZD-5335 by AstraZeneca for Ovarian Cancer: Likelihood of Approval
AZD-5335 is under clinical development by AstraZeneca and currently in Phase II for Ovarian Cancer. According to GlobalData, Phase II...
AZD-5335 by AstraZeneca for Lung Adenocarcinoma: Likelihood of Approval
AZD-5335 is under clinical development by AstraZeneca and currently in Phase II for Lung Adenocarcinoma. According to GlobalData, Phase II...